Shi W X, Smith P L, Pun C L, Millet B, Bunney B S
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
J Neurosci. 1997 Oct 15;17(20):7988-94. doi: 10.1523/JNEUROSCI.17-20-07988.1997.
Dopamine (DA) D1-like receptors are present in pathways implicated in feedback control of midbrain DA neurons. However, stimulation of these receptors either produces no effect on DA cells, or the effect is inconsistent. It is possible that the expression of a D1 feedback effect requires co-activation of D2-like receptors. To test this hypothesis, we recorded extracellularly the spontaneous activity of nigral DA cells in a low cerveau isolé rat preparation. SKF38393 and dyhydrexidine, two D1 agonists, were administered systemically to animals pretreated with different doses of the D2 agonist quinpirole. Supporting the hypothesis, the two D1 agonists consistently inhibited DA cells in animals given high doses of quinpirole (>/=40 microg/kg, i.v.). However, no significant D1 effect was observed in animals pretreated with only low doses (</=20 microg/kg) of quinpirole. Because low doses of D2 agonists preferentially act on DA autoreceptors, and because the D1 inhibition persisted in animals whose DA autoreceptors were blocked by intranigral application of raclopride, our results suggest that the expression of D1 feedback inhibition requires co-activation of D2-like receptors on DA target neurons, instead of DA neurons themselves. These results, together with the finding that chloral hydrate completely blocked the D1 inhibition, may explain why previous studies have failed to show a consistent D1 effect on DA cells and suggest that drugs designed to act specifically on one subtype of DA receptor may, via feedback pathways, influence the action of endogenous DA on other DA receptor subtypes as well.
多巴胺(DA)D1样受体存在于与中脑DA神经元反馈控制有关的通路中。然而,刺激这些受体对DA细胞要么没有影响,要么影响不一致。D1反馈效应的表达可能需要D2样受体的共同激活。为了验证这一假设,我们在低脑孤立大鼠制备中细胞外记录黑质DA细胞的自发活动。将两种D1激动剂SKF38393和二氢麦角隐亭系统地给予用不同剂量D2激动剂喹吡罗预处理的动物。支持该假设的是,在给予高剂量喹吡罗(≥40μg/kg,静脉注射)的动物中,这两种D1激动剂持续抑制DA细胞。然而,在用低剂量(≤20μg/kg)喹吡罗预处理的动物中未观察到明显的D1效应。由于低剂量的D2激动剂优先作用于DA自身受体,并且由于D1抑制在黑质内应用雷氯必利阻断其DA自身受体的动物中持续存在,我们的结果表明D1反馈抑制的表达需要DA靶神经元上D2样受体的共同激活,而不是DA神经元本身。这些结果,连同水合氯醛完全阻断D1抑制的发现,可能解释了为什么先前的研究未能显示对DA细胞有一致的D1效应,并表明设计用于特异性作用于一种DA受体亚型的药物可能通过反馈途径影响内源性DA对其他DA受体亚型的作用。